secwatch.observer — SEC 8-K summary
======================================

Issuer:     ANAVEX LIFE SCIENCES CORP. (AVXL)
CIK:        0001314052
Form:       8-K
Filed at:   2026-05-15T20:15:25+00:00
Accession:  0001731122-26-000744
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Anavex COO Felix Lauscher departs May 11 amid reorganization after interim CEO
------------------------------------------------------------------------------

- Felix Lauscher, COO since March 1, 2026, left Anavex on May 11, 2026.
- Departure part of broader reorganization after appointing Dr. Terrie Kellmeyer as Interim CEO.
- Lauscher had $264K annual base salary; received prorated pay for service period.
- Of 50,000 stock options granted, 45,833 forfeited; 4,167 vested at $4.69/share exercisable until Aug 9, 2026.
- Offered two weeks' additional compensation at base salary in exchange for general release.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1314052/000173112226000744/0001731122-26-000744-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1314052/000173112226000744/e7648_8k.htm
  HTML page:      https://secwatch.observer/filing/0001731122-26-000744

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer